pharmaphorum2d
Tris cues up filing for non-opioid pain drug on phase 3 win
The new data comes from the phase 3 ALLEVIATE-1 trial, which compared cebranopadol to placebo for the management of ...
Hosted on MSN1d
Researchers made an AI feel pain, because what could go wrong?
Pleasure and pain are important factors in how we humans make decisions. So why not give artificial intelligence a taste of ...
Too Old to Operate1d
Cancer Pain Management Insights from Healthcare Professionals
The following is a summary of “Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of ...
Hosted on MSN12mon
Experimental pain drug may offer alternative to opioids for acute pain, study suggests
But it showed similar relief to the opioid on a measure known as the Numeric Pain Rating Scale. The results, combined with those from previous trials, suggest that VX-548 has “an unprecedented ...
Too Old to Operate2d
A 9-Week rTMS Intervention for Pain Relief in Complex Regional Pain Syndrome
The following is a summary of “Repetitive Transcranial Magnetic Stimulation for the Treatment of Complex Regional Pain Syndrome: A Pilot Study,” published in the January 2025 issue of Pain by Foglia ...
clinicaltrialsarena on MSN2d
Tris Pharma reports positive data from Phase III acute pain therapy trial
Tris Pharma has reported positive outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol to treat moderate-to-severe ...